已收盘 08-01 16:00:00 美东时间
+0.070
+0.67%
Ratings for Gilead Sciences (NASDAQ:GILD) were provided by 10 analysts in the p...
05-22 04:00
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.68) by 23.53 percent. This is a 79.28 percent increase over losses of $(2.51) per share from the same
05-13 04:26
Whales with a lot of money to spend have taken a noticeably bullish stance on G...
04-24 02:01
Gilead Sciences (NASDAQ:GILD) will release its quarterly earnings report on Thu...
04-23 22:02
Gilead Sciences (NASDAQ:GILD) has been analyzed by 15 analysts in the last thre...
04-22 22:01
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Saturday - April 5...
04-05 03:00
Analysts' ratings for Gilead Sciences (NASDAQ:GILD) over the last quarter vary ...
03-28 03:01
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-27 07:00
Immunome (NASDAQ:IMNM) stock rose about 5% after the company's Director and Chief Technology Officer disclosed share purchase. Philip Tsai, Chief Technology Officer, bought 12,300 shares at $8.42 per...
03-26 23:16